Image
Image
Image
Image
Image
Image
Image

St. Jude-VIVA World Speaker Series Day 2

圣裘德-VIVA 线上论坛 - 世界演讲者系列(二)

26-3-2022  |  08.00 - 09:00PM (UTC+8)  
Check your Time Zone 

World Speaker Series Day 2  世界演讲者系列(二)

 

In this series, our guest speaker, Professor Michael A. Pulsipher from University of Utah Health, USA will be sharing about the Best Approaches to Tisagenlecleucel Treatment in Children and Young Adults with ALL: Risk Factors, When to Transplant, and Salvage of Relapse after CAR T-cell Therapy.
Don’t miss! Click the button below to register.
We look forward to seeing you.

在这一系列中,我们的嘉宾演讲人,来自美国犹他大学的Michael A. Pulsipher教授将分享关于急性淋巴细胞白血病患儿和年轻人Tisagenlecleucel治疗的最佳方法:风险因素、何时移植以及CAR T细胞治疗后复发的挽救。
别错过!点击下面的按钮注册。
如果你不能参加,你仍然可以注册以接收一份网络研讨会录音。

 

Medical professionals in Singapore may be eligible for CME/CNE/CPE credits for attending this webinar, once approved (application pending). Credits and Certificates of Attendance will only be issued for those who are able to attend the live session and are in adherence with VIVA's Attendance Policy

KEY SPEAKER 主讲者

Prof Michael A. Pulsipher

Prof Michael A. Pulsipher

MD 医学博士
Professor of Pediatrics 儿科主任医师
Division Chief, Pediatric Hematology and Oncology 儿科血液学和肿瘤科科长
Director, Children’s and Adolescent Cancer Initiative at Huntsman Cancer Institute and Intermountain 
Primary Children’s Hospital 洪博培癌症研究所和山间小学儿童医院儿童和青少年癌症倡议主任
IPCH-HCI Presidential Chair in Pediatric Oncology and Hematology 儿童肿瘤学和血液学IPCH-HCI主席
Huntsman Cancer Institute at the University of Utah 犹他大学亨茨曼癌症研究所
USA 美国

MODERATOR 主持

Dr Michaela Seng 

Dr Michaela Seng 

MBBS, MRCPCH (UK), FAMS, FRACP
Consultant
Haematology/Oncology Department
KK Women's and Children's Hospital
Singapore